Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial
For example, the improvements in cardiovascular outcome have been evidenced in a number of large-scale randomized controlled clinical trials on cardiovascular disease (102)
These versions, unlike generics, are not FDA-approved
The platform is relatively new (launched June 2025), which explains the limited independent review presence
The Promise of GLP-1 Drugs: More Than Just Diabetes Management When GLP-1 (Glucagon-Like Peptide-1) receptor agonists first hit the market, they were hailed as a breakthrough in type 2 diabetes
Key Takeaways GLP-1 medications can reduce appetite and food intake, which may make it harder to meet daily nutrient needs during weight loss